{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:30:55Z","timestamp":1786710655622,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:00:00Z","timestamp":1783209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.dld.2026.07.004","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:32:09Z","timestamp":1785324729000},"page":"1217-1218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Author\u2019s reply: \u201cFibrate therapy in primary sclerosing cholangitis\""],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7622-6051","authenticated-orcid":false,"given":"E.","family":"Catanzaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6937-8664","authenticated-orcid":false,"given":"N.","family":"Cazzagon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.dld.2026.07.004_bib0001","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.dld.2026.04.017","article-title":"Long-term add-on fibrate therapy in primary sclerosing cholangitis: safety, biochemical response, and disease progression","volume":"58","author":"Catanzaro","year":"2026","journal-title":"Dig Liver Dis"},{"issue":"9","key":"10.1016\/j.dld.2026.07.004_bib0002","first-page":"1215","article-title":"Fibrate therapy in primary sclerosing cholangitis: missing data on lipids, interactions, and cancer risk","volume":"58","author":"Wu","year":"2026","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.dld.2026.07.004_bib0003","first-page":"31","article-title":"Statins, fibrates, and other peroxisome proliferator-activated receptor agonists for the treatment of cholestatic liver diseases","volume":"16","author":"Dubrovsky","year":"2020","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"7","key":"10.1016\/j.dld.2026.07.004_bib0004","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/MEG.0000000000003146","article-title":"Cardiovascular risk profiles in patients with primary sclerosing cholangitis","volume":"38","author":"Sleutjes","year":"2026","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.dld.2026.07.004_bib0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90175-w","article-title":"Primary sclerosing cholangitis and the risk of cancer, cardiovascular disease, and all-cause mortality: a systematic review and meta-analysis of cohort studies","volume":"11","author":"Aune","year":"2021","journal-title":"Sci Rep"},{"issue":"10S","key":"10.1016\/j.dld.2026.07.004_bib0006","doi-asserted-by":"crossref","first-page":"S1119","DOI":"10.14309\/01.ajg.0000955528.44907.21","article-title":"S1472 Risk of cardiovascular disease in primary sclerosing cholangitis","volume":"118","author":"Celaj","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.dld.2026.07.004_bib0008","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/hep4.1787","article-title":"Adjunct fenofibrate up-regulates bile acid glucuronidation and improves treatment response for patients with cholestasis","volume":"5","author":"Gallucci","year":"2021","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1016\/j.dld.2026.07.004_bib0007","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/0091270010366446","article-title":"Effect of gemfibrozil and fenofibrate on the pharmacokinetics of atorvastatin","volume":"51","author":"Whitfield","year":"2011","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.dld.2026.07.004_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2013.835784","article-title":"Mode of action framework analysis for receptor-mediated toxicity: the peroxisome proliferator-activated receptor alpha (PPAR \u03b1) as a case study","volume":"44","author":"Corton","year":"2014","journal-title":"Crit Rev Toxicol"},{"issue":"9","key":"10.1016\/j.dld.2026.07.004_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045259","article-title":"Use of Fibrates and cancer risk: a systematic review and meta-analysis of 17 long-term randomized placebo-controlled trials. Gluud C, ed","volume":"7","author":"Bonovas","year":"2012","journal-title":"PLoS ONE"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826007917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865826007917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T11:36:24Z","timestamp":1786707384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865826007917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1590865826007917"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2026.07.004","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Author\u2019s reply: \u201cFibrate therapy in primary sclerosing cholangitis\"","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.04.017","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2026.06.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}